{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:20:16Z","timestamp":1790698816478,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008644","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T13:24:43Z","timestamp":1602509083000},"page":"e0008644","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring &amp; evaluating (M&amp;E) programmes post the cessation of mass drug administration (MDA)"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6773-408X","authenticated-orcid":true,"given":"Benjamin S.","family":"Collyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Deidre","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7377-3213","authenticated-orcid":true,"given":"Mark","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"pntd.0008644.ref001","volume-title":"Global programme to eliminate lymphatic filariasis: progress report, 2013","year":"2014"},{"key":"pntd.0008644.ref002","unstructured":"World Health Organization. WHO Lyphatic filariasis fact-sheet 2019 [cited 2019 12\/11\/2019]. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/lymphatic-filariasis."},{"key":"pntd.0008644.ref003","volume-title":"Elimination of lymphatic filariasis as a public health problem\u2014resolution of the executive board of the wHO (wHA50.29)","year":"1997"},{"key":"pntd.0008644.ref004","unstructured":"Global Programme to Eliminate Lymphatic Filariasis. Progress Report 2000\u20132009 and Strategic Plan 2010\u20132020. Geneva: WHO\/HTM\/NTD\/PCT\/2010.2016; 2010 2010\/\/."},{"key":"pntd.0008644.ref005","volume-title":"Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation: executive summary","author":"World Health Organization","year":"2012"},{"key":"pntd.0008644.ref006","unstructured":"London Declaration on Neglected Tropical Diseases Ending the neglect and reaching 2020 goals 2012 [12\/11\/2019]. Available from: http:\/\/www.who.int\/neglected_diseases\/NTD_RoadMap_2012_Fullversion.pdf."},{"key":"pntd.0008644.ref007","volume-title":"Monitoring and Epidemiological Assessment of Mass Drug Administration","author":"Global Programme to Eliminate Lymphatic Filariasis","year":"2011"},{"key":"pntd.0008644.ref008","volume-title":"Global programme to eliminate lymphatic filariasis: progress report, 2017.","year":"2018"},{"key":"pntd.0008644.ref009","volume-title":"Guideline\u2013Alternative mass drug administration regimens to eliminate lymphatic filariasis","year":"2017"},{"key":"pntd.0008644.ref010","volume-title":"Samoa rolls out triple drug therapy to accelerate elimination of lymphatic filariasis","author":"World Health Organization.","year":"2018"},{"key":"pntd.0008644.ref011","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s13071-015-1157-y","article-title":"What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?","volume":"8","author":"RM Anderson","year":"2015","journal-title":"Parasites & vectors."},{"issue":"1","key":"pntd.0008644.ref012","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1186\/s13071-015-1152-3","article-title":"Modelling strategies to break transmission of lymphatic filariasis\u2014aggregation, adherence and vector competence greatly alter elimination.","volume":"8","author":"MA Irvine","year":"2015","journal-title":"Parasites & Vectors."},{"key":"pntd.0008644.ref013","first-page":"133","volume-title":"Chapter Three\u2014Soil-Transmitted Helminths: Mathematical Models of Transmission, the Impact of Mass Drug Administration and Transmission Elimination Criteria.","author":"JE Truscott","year":"2016"},{"issue":"11","key":"pntd.0008644.ref014","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.pt.2019.08.003","article-title":"Evaluating the Evidence for Lymphatic Filariasis Elimination","volume":"35","author":"EL Davis","year":"2019","journal-title":"Trends in Parasitology"},{"key":"pntd.0008644.ref015","article-title":"Elimination or Resurgence: Modelling Lymphatic Filariasis After Reaching the 1% Microfilaremia Prevalence Threshold","author":"JM Prada","year":"2019","journal-title":"The Journal of Infectious Diseases"},{"key":"pntd.0008644.ref016","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-017-2256-8","article-title":"Identifying optimal threshold statistics for elimination of hookworm using a stochastic simulation model.","volume":"10","author":"JE Truscott","year":"2017","journal-title":"Parasites & Vectors."},{"issue":"1","key":"pntd.0008644.ref017","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s13071-019-3611-8","article-title":"Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission.","volume":"12","author":"J Toor","year":"2019","journal-title":"Parasites & Vectors."},{"issue":"1","key":"pntd.0008644.ref018","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13071-017-1979-x","article-title":"Assessing the interruption of the transmission of human helminths with mass drug administration alone: optimizing the design of cluster randomized trials.","volume":"10","author":"R Anderson","year":"2017","journal-title":"Parasites & Vectors."},{"key":"pntd.0008644.ref019","article-title":"Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in papua new guinea.","volume":"8","author":"BK Singh","year":"2013","journal-title":"PLoS One."},{"key":"pntd.0008644.ref020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.epidem.2017.02.006","article-title":"Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework.","volume":"18","author":"ME Smith","year":"2017","journal-title":"Epidemics"},{"key":"pntd.0008644.ref021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.epidem.2018.05.009","article-title":"Kernel-density estimation and approximate Bayesian computation for flexible epidemiological model fitting in Python.","volume":"25","author":"MA Irvine","year":"2018","journal-title":"Epidemics"},{"key":"pntd.0008644.ref022","article-title":"What is needed to eradicate lymphatic filariasis? A model-based assessment on the impact of scaling up mass drug administration programs.","author":"RJ Kastner","year":"2015","journal-title":"PLoS NTDs."},{"key":"pntd.0008644.ref023","article-title":"On the inefficiency of transmission of wuchereria bancrofti from mosquito to human host","volume":"38","author":"NG Hairston","year":"1968","journal-title":"Bull World Health Organ"},{"key":"pntd.0008644.ref024","article-title":"Experimental transmission of filarial larvae in relation to feeding behaviour of the mosquito vectors","volume":"61","author":"BC Ho","year":"1967","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008644.ref025","first-page":"124","article-title":"EPIFIL: The development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis","author":"R Norman","year":"2000","journal-title":"Epidemiol Infect"},{"key":"pntd.0008644.ref026","first-page":"135","article-title":"LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: Quantification for african villages","author":"WA Stolk","year":"2008","journal-title":"Parasitology"},{"key":"pntd.0008644.ref027","doi-asserted-by":"crossref","DOI":"10.1016\/0001-706X(93)90002-S","article-title":"Social and economic factors and the control of lymphatic filariasis: a review","volume":"53","author":"DB Evans","year":"1993","journal-title":"Acta Trop"},{"key":"pntd.0008644.ref028","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7007-8-22","article-title":"Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.","volume":"8","author":"M Gambhir","year":"2010","journal-title":"BMC Biol."},{"key":"pntd.0008644.ref029","first-page":"11","article-title":"Lymphatic filariasis infection and disease: control strategies","author":"E Ottesen","year":"1995","journal-title":"Parasitol Today"},{"key":"pntd.0008644.ref030","doi-asserted-by":"crossref","DOI":"10.1017\/S0031182097002254","article-title":"The relationship between microfilarial load in the human host and uptake and development of wuchereria bancrofti microfilariae by culex quinquefasciatus: a study under natural conditions","volume":"116","author":"S Subramanian","year":"1998","journal-title":"Parasitology"},{"key":"pntd.0008644.ref031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002874","article-title":"Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.","volume":"3","author":"M Gambhir","year":"2008","journal-title":"PLoS One."},{"key":"pntd.0008644.ref032","doi-asserted-by":"crossref","DOI":"10.1016\/S0035-9203(98)90972-5","article-title":"Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis","volume":"92","author":"M Ismail","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008644.ref033","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(04)00973-9","article-title":"Mathematical modelling and the control of lymphatic filariasis","volume":"4","author":"E Michael","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"pntd.0008644.ref034","article-title":"Mathematical modelling of lymphatic filariasis elimination programs in India: required duration of mass drug administration and post-treatment level of infection indicators.","author":"C Vinubala","year":"2015","journal-title":"Parasite Vector"},{"issue":"8","key":"pntd.0008644.ref035","doi-asserted-by":"crossref","first-page":"e2874","DOI":"10.1371\/journal.pone.0002874","article-title":"Complex Ecological Dynamics and Eradicability of the Vector Borne Macroparasitic Disease, Lymphatic Filariasis.","volume":"3","author":"M Gambhir","year":"2008","journal-title":"PLOS ONE."},{"key":"pntd.0008644.ref036","article-title":"The lYMFASIM simulation program for modeling lymphatic filariasis and its control.","volume":"37","author":"A Plaisier","year":"1998","journal-title":"Methods Inf Med."},{"issue":"6","key":"pntd.0008644.ref037","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4269\/ajtmh.15-0916","article-title":"Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer","volume":"94","author":"CB Chesnais","year":"2016","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"4","key":"pntd.0008644.ref038","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4269\/ajtmh.2000.62.502","article-title":"Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment","volume":"62","author":"A Schuetz","year":"2000","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"pntd.0008644.ref039","volume-title":"Infectious diseases of humans","author":"RM Anderson","year":"1992"},{"issue":"8","key":"pntd.0008644.ref040","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/j.ijid.2010.06.020","article-title":"Super-spreaders in infectious diseases","volume":"15","author":"RA Stein","year":"2011","journal-title":"International Journal of Infectious Diseases"},{"key":"pntd.0008644.ref041","article-title":"Estimation of fecundic life span of wuchereria bancrofti from longitudinal study of human infection in an endemic area of pondicherry (south india).","volume":"91","author":"P Vanamail","year":"1990","journal-title":"Indian J Med Res"},{"key":"pntd.0008644.ref042","first-page":"128","article-title":"The dynamics of wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India.","author":"S Subramanian","year":"2004","journal-title":"Parasitology"},{"issue":"12","key":"pntd.0008644.ref043","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.trstmh.2005.05.006","article-title":"Does longevity of adult Wuchereria bancrofti increase with decreasing intensity of parasite transmission? Insights from clinical observations","volume":"99","author":"G Dreyer","year":"2005","journal-title":"Transactions of The Royal Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"pntd.0008644.ref044","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4269\/ajtmh.1979.28.53","article-title":"Longevity of Wuchereria bancrofti var. pacifica and mosquito infection acquired from a patient with low level parasitemia","volume":"28","author":"B Carme","year":"1979","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"9747","key":"pntd.0008644.ref045","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"MJ Taylor","year":"2010","journal-title":"The Lancet"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T13:25:11Z","timestamp":1602509111000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008644"}},"subtitle":[],"editor":[{"given":"Sabine","family":"Specht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008644","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]}}}